13F
中

CRVO CERVOMED INC

2026Q1 · CUSIP 15713L109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
36
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
19
Δ whales
-2
Inst. holding value
$7M
New positions
7
Closed positions
19
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2023Q4: Δ+0 · h=13 2024Q1: Δ+8 · h=21 2024Q2: Δ+18 · h=39 2024Q3: Δ+12 · h=51 2024Q4: Δ-1 · h=50 2025Q1: Δ-1 · h=49 2025Q2: Δ-3 · h=46 2025Q3: Δ-1 · h=45 2025Q4: Δ+3 · h=48 2026Q1: Δ-12 · h=36 2023Q4: holders=13 2024Q1: holders=21 2024Q2: holders=39 2024Q3: holders=51 2024Q4: holders=50 2025Q1: holders=49 2025Q2: holders=46 2025Q3: holders=45 2025Q4: holders=48 2026Q1: holders=36 -18 -9 +0 +9 +18 113354 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 15% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.28
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-77.6%
Quarterly Revenue & EPS (4Y)
2024-03-31: $2M 2024-06-30: $3M 2024-09-30: $2M 2024-12-31: $2M 2025-03-31: $2M 2025-06-30: $2M 2025-09-30: $0M 2025-12-31: $0M 2026-03-31: $0M 2021-03-31: EPS 20855046.00 2021-06-30: EPS 25475994.75 2021-09-30: EPS 25475994.75 2022-03-31: EPS -0.56 2022-06-30: EPS -0.52 2024-03-31: EPS -0.41 2024-06-30: EPS -0.27 2024-09-30: EPS -0.55 2024-12-31: EPS -0.79 2025-03-31: EPS -0.56 2025-06-30: EPS -0.70 2025-09-30: EPS -0.84 2025-12-31: EPS -0.88 2026-03-31: EPS -0.86 0M 2M 3M $M -0.97 14011796.63 28023594.23 20212022202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 0 2022-03-31: PE 02022-06-30: PE 02024-03-31: PE 0 0 0 0 20212022202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)